440
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Etodolac nanosuspension based gel for enhanced dermal delivery: in vitro and in vivo evaluation

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 218-232 | Received 26 Oct 2020, Accepted 17 Feb 2021, Published online: 23 Mar 2021

References

  • Abdelghany, S., et al., 2019. Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin. Pharmaceutics, 11 (7), 308.
  • Ain-Ai, A. and Gupta, P.K., 2008. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. International journal of pharmaceutics, 351 (1–2), 282–288.
  • Augsburger, L. L. and Hoag, S. W., 2016. Pharmaceutical dosage forms-tablets. Boca Raton, FL: CRC Press.
  • Balzus, B., et al., 2016. Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application. International journal of pharmaceutics, 513 (1–2), 247–254.
  • Baumgartner, S., et al., 2005. Quantitative evaluation of polymer concentration profile during swelling of hydrophilic matrix tablets using 1H NMR and MRI methods. European journal of pharmaceutics and biopharmaceutics, 59 (2), 299–306.
  • Bolla, P.K., et al., 2020. Evaluation of formulation parameters on permeation of ibuprofen from topical formulations using Strat-M® membrane. Pharmaceutics, 12 (2), 151.
  • Casiraghi, A., et al., 2016. Topical treatment of infantile haemangiomas: a comparative study on the selection of a semi-solid vehicle. Skin pharmacology and physiology, 29 (4), 210–219.
  • Chintala, P.K. and Nadu, T., 2014. Formulation and in vitro evaluation of gel containing ethosomes etrapped with ethodolac. International journal of pharmaceutical sciences and research, 5 (2), 630–635.
  • Cui, B., et al., 2019. Improving abamectin bioavailability via nanosuspension constructed by wet milling technique. Pest management science, 75 (10), 2756–2764.
  • Eftimov, P., et al., 2015. Effect of hydrophilic polymers on the wettability, static and dynamic, of solid substrate covered by confluent monolayer of air-damaged SIRC cells. Biotechnology & biotechnological equipment, 29 (2), 390–394.
  • Fayez, S.M., et al., 2015. Formulation and evaluation of etodolac lecithin organogel transdermal delivery systems. International journal of pharmacy and pharmaceutical sciences, 7 (4), 325–334.
  • Fu, T., et al., 2020. Study on the stabilization mechanisms of wet-milled cepharanthine nanosuspensions using systematical characterization. Drug development and industrial pharmacy, 0 (0), 1–9.
  • Gao, Y., Qian, S., and Zhang, J., 2010. Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension. Chemical & pharmaceutical bulletin, 58 (7), 912–917.
  • Ghosal, K. and Nanda, A., 2013. Development of diclofenac potassium gel from hydrophobically modified HPMC. Iranian polymer journal, 22 (6), 457–464.
  • Ghosh, I. and Michniak-Kohn, B., 2013. Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin-a case study. AAPS PharmSciTech, 14 (3), 1108–1117.
  • Goindi, S., Kaur, R., and Kaur, R., 2015. An ionic liquid-in-water microemulsion as a potential carrier for topical delivery of poorly water soluble drug: Development, ex-vivo and in-vivo evaluation. International journal of pharmaceutics, 495 (2), 913–923.
  • Gondkar, S.B., Patil, N.R., and Saudagar, R.B., 2017. Formulation development and characterization of etodolac loaded transethosomes for transdermal delivery. Research journal of pharmacy and technology, 10 (9), 3049.
  • Gouda, A.A., et al., 2013. Spectrophotometric and spectrofluorometric methods for the determination of non-steroidal anti-inflammatory drugs: a review. Arabian journal of chemistry, 6 (2), 145–163.
  • Gülbağ Pinar, S. and Çelebi, N., 2019. Optimization and evaluation of cyclosporine a nanosuspension stabilized by combination stabilizers using high pressure homogenization method. Sanat tasarim dergisi, 23 (6), 1009–1021.
  • Hatahet, T., et al., 2016. Dermal quercetin smartCrystals®: formulation development, antioxidant activity and cellular safety. European journal of pharmaceutics and biopharmaceutics, 102, 51–63.
  • He, W., et al., 2013a. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs. International journal of pharmaceutics, 441 (1–2), 269–278.
  • He, W., et al., 2013b. Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: Physical characterization, redispersibility, and dissolution. International journal of nanomedicine, 8, 3119–3128.
  • Hoare, T.R. and Kohane, D.S., 2008. Hydrogels in drug delivery: progress and challenges. Polymer, 49 (8), 1993–2007.
  • Hurler, J., et al., 2012. Improved texture analysis for hydrogel characterization: gel cohesiveness, adhesiveness, and hardness. Journal of applied polymer science, 125 (1), 180–188.
  • Ilbasmis-Tamer, S., et al., 2016. Stimuli-responsive lipid nanotubes in gel formulations for the delivery of doxorubicin. Colloids and surfaces B biointerfaces, 143, 406–414.
  • Jacob, S., Nair, A.B., and Shah, J., 2020. Emerging role of nanosuspensions in drug delivery systems. Biomaterials research, 24 (3), 3–16.
  • Jin, N., et al., 2019. Azithromycin nanocrystals for dermal prevention of tick bite infections. Die pharmazie, 74 (5), 277–285.
  • Jitkar, S., et al., 2016. Spherical agglomeration of platy crystals: curious case of etodolac. Crystal growth & design, 16 (7), 4034–4042.
  • Jones, D.S., Woolfson, A.D., and Brown, A.F., 1997. Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharmaceutical research, 14 (4), 450–457.
  • Jones, R.A., 1999. Etodolac: an overview of a selective COX-2 inhibitor. Inflammopharmacology, 7 (3), 269–275.
  • Kadioglu, Y., 2013. Quantitative determination of etodolac by uv spectrophtometric method in bulk drug and commercial formulations. International journal of pharmaceutical sciences and research, 4 (8), 2927–2932.
  • Karakucuk, A. and Celebi, N., 2020. Investigation of formulation and process parameters of wet media milling to develop etodolac nanosuspensions. Pharmaceutical research, 37 (6), 111–118.
  • Knoth, D., et al., 2019. Evaluation of a biosurfactant extract obtained from corn for dermal application. International journal of pharmaceutics, 564, 225–236.
  • Lehr, C.M., et al., 1992. A surface energy analysis of mucoadhesion: contact angle measurements on polycarbophil and pig intestinal mucosa in physiologically relevant fluids. Pharmaceutical research, 9 (1), 70–75.
  • Letha, S. P. S., and Viswanad, V., 2017. Formulation and evaluation of etodolac pharmacosomes: a novel approach towards rheumatoid arthritis. International journal of pharmacy & technology, 9 (1), 28100–28105.
  • Madhavi, N., et al., 2019. Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery. Drug development and industrial pharmacy, 45 (4), 611–628.
  • Manca, M.L., et al., 2020. Impact of nanosizing on dermal delivery and antioxidant activity of quercetin nanocrystals. Journal of drug delivery science and technology, 55, 101482.
  • Medarević, D., et al., 2018. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling. International journal of pharmaceutics, 540 (1–2), 150–161.
  • de Miranda Silva, C., et al., 2017. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS journal, 19 (6), 1814–1825.
  • Morris, C.J., 2003. Carrageenan-induced paw edema in the rat and mouse. Methods in molecular biology, 225, 115–121.
  • Möschwitzer, J.P., 2013. Drug nanocrystals in the commercial pharmaceutical development process. International journal of pharmaceutics, 453 (1), 142–156.
  • Müller, R.H., Gohla, S., and Keck, C.M., 2011. State of the art of nanocrystals-special features, production, nanotoxicology aspects and intracellular delivery. European journal of pharmaceutics and biopharmaceutics, 78 (1), 1–9.
  • Nantel, F., et al., 1999. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. British journal of pharmacology, 128 (4), 853–859.
  • Nayak, A., et al., 2015. Spreading of a lidocaine formulation on microneedle-treated skin. Journal of pharmaceutical sciences, 104 (12), 4109–4116.
  • Noufou, O., et al., 2012. Pharmacological properties and related constituents of stem bark of Pterocarpus erinaceus Poir (Fabaceae). Asian pacific journal of tropical medicine, 5 (1), 46–51.
  • Oktay, A.N., et al., 2020. Screening of stabilizing agents to optimize flurbiprofen nanosuspensions using experimental design. Journal of drug delivery science and technology, 57, 101690.
  • Oktay, A.N., et al., 2018. Dermal flurbiprofen nanosuspensions: optimization with design of experiment approach and in vitro evaluation. European journal of pharmaceutical sciences, 122, 254–263.
  • Okur, M.E., et al., 2019. Evaluation of in situ gel containing pycnogenol for cutaneous wound healing. Medeniyet medical journal, 34 (1), 67–75.
  • Pal, R., 2016. Modeling the viscosity of concentrated nanoemulsions and nanosuspensions. Fluids, 1 (2), 11.
  • Patel, H.M., Patel, B.B., and Shah, C.N., 2016.Nanosuspension: a novel approach to enhance solubility of poorly water soluble drugs - A review. International journal of advances in pharmaceutics, 5 (2), 21–29.
  • Permana, A.D., McCrudden, M.T.C., and Donnelly, R.F., 2019. Enhanced intradermal delivery of nanosuspensions of antifilariasis drugs using dissolving microneedles: a proof of concept study. Pharmaceutics, 11 (7), 1–22.
  • Pireddu, R., et al., 2018. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions. Colloids and surfaces B biointerfaces, 162, 8–15.
  • Pyo, S.M., et al., 2017. Dermal miconazole nitrate nanocrystals – formulation development, increased antifungal efficacy & skin penetration. International journal of pharmaceutics, 531 (1), 350–359.
  • Pyo, S.M., et al., 2016. Rutin-increased antioxidant activity and skin penetration by nanocrystal technology (smartCrystals). Cosmetics, 3 (1), 9.
  • Rana, P. and Murthy, R.S.R., 2013. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism. Drug delivery, 20 (5), 224–235.
  • Rasool, B.K.A., et al., 2010. Development and evaluation of ibuprofen transdermal gel formulations. Tropical journal of pharmaceutical research, 9 (4), 355–363.
  • Salah, S., Mahmoud, A.A., and Kamel, A.O., 2017. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug delivery, 24 (1), 846–856.
  • Sezer, A.D., et al., 2007. Chitosan film containing fucoidan as a wound dressing for dermal burn healing: preparation and in vitro/in vivo evaluation. AAPS PharmSciTech, 8 (2), E94–8.
  • Sharma, G., et al., 2016. Aceclofenac-β-cyclodextrin-vesicles: a dual carrier approach for skin with enhanced stability, efficacy and dermatokinetic profile. RSC advances, 6 (25), 20713–20727.
  • Shen, C., et al., 2018. Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability. Journal of drug delivery science and technology, 43, 1–11.
  • Shilakari Asthana, G., et al., 2016. Etodolac containing topical niosomal gel: formulation development and evaluation. Journal of drug delivery, 2016, 9324567–9324568.
  • Stahr, P.L. and Keck, C.M., 2019. Preservation of rutin nanosuspensions without the use of preservatives. Beilstein journal of nanotechnology, 10, 1902–1913.
  • Sun, K., et al., 2018. Evaluation of analgesic and anti-inflammatory activities of water extract of galla chinensis in vivo models. Evidence-based complementary and alternative medicine, 2018 (6784032), 1–7.
  • Tas, C., et al., 2007. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug delivery, 14 (7), 453–459.
  • Toziopoulou, F., et al., 2017. Production of aprepitant nanocrystals by wet media milling and subsequent solidification. International journal of pharmaceutics, 533 (2), 324–334.
  • Tuğcu-Demiröz, F., 2017a. Vaginal delivery of benzydamine hydrochloride through liposomes dispersed in mucoadhesive gels. Chemical & pharmaceutical bulletin, 65 (7), 660–667.
  • Tuğcu-Demiröz, F., 2017b. Development of in situ poloxamer-chitosan hydrogels for vaginal drug delivery of benzydamine hydrochloride: textural, mucoadhesive and in vitro release properties. Marmara pharmaceutical journal, 21 (4), 762–770.
  • Uchechi, O., Ogbonna, J. D. N., and Attama, A. A., 2014. Nanoparticles for dermal and transdermal drug delivery. In: A.D. Sezer, ed. Application of nanotechnology in drug delivery. London, UK: IntechOpen, 193-235.
  • Vázquez Rodríguez, C. F., et al., 2000. Hydrophilic cellulose derivatives as drug delivery carriers: influence of substitution type on the properties. In: D.L. Wise, ed. Handbook of pharmaceutical controlled release technology (1st ed.). Boca Raton, FL: CRC Press, 1–30.
  • Vedaga, S.B., Gondkar, S.B., and Saudagar, R.B., 2019. Nanosuspension: an emerging trend to improve solubility of poorly water soluble drugs. Journal of drug delivery and therapeutics, 9 (3 SE-Review), 549–553.
  • Karavana, S.Y., Güneri, P., and Ertan, G., 2009. Benzydamine hydrochloride buccal bioadhesive gels designed for oral ulcers: preparation, rheological, textural, mucoadhesive and release properties. Pharmaceutical development and technology, 14 (6), 623–631.
  • Yue, P.F., et al., 2013. Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property. International journal of pharmaceutics, 454 (1), 269–277.
  • Zhai, X., et al., 2014. Nanocrystals of medium soluble actives-novel concept for improved dermal delivery and production strategy. International journal of pharmaceutics, 470 (1–2), 141–150.
  • Zhang, J., et al., 2017. Nanosuspension drug delivery system: preparation, characterization, postproduction processing, dosage form, and application. In: E. Andronescu and A.M. Grumezescu, eds. Nanostructures for drug delivery. London: Elsevier, 413-443.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.